(Q44426764)

English

Comparative in vitro potency of amoxycillin–clavulanic acid and four oral agents against recent North American clinical isolates from a global surveillance study

scientific article published on May 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Comparative in vitro potency of amoxycillin-clavulanic acid and four oral agents against recent North American clinical isolates from a global surveillance study (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Comparative in vitro potency of amoxycillin–clavulanic acid and four oral agents against recent North American clinical isolates from a global surveillance study (English)

1 reference

10.1016/S0924-8579(03)00038-4

https://api.crossref.org/works/10.1016/S0924-8579(03)00038-4

29 December 2023

bacterial drug resistance

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12727075

29 December 2023

author name string

Surveillance Study Research Group

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

D. J. Hoban

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12727075

29 December 2023

S. K. Bouchillon

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12727075

29 December 2023

J. L. Johnson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12727075

29 December 2023

G. G. Zhanel

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12727075

29 December 2023

D. L. Butler

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12727075

29 December 2023

K. A. Saunders

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12727075

29 December 2023

L. A. Miller

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12727075

29 December 2023

J. A. Poupard

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12727075

29 December 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12727075

29 December 2023

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0924857903000384?httpAccept=text/xml

1 reference

10.1016/S0924-8579(03)00038-4

https://api.crossref.org/works/10.1016/S0924-8579(03)00038-4

29 December 2023

https://api.elsevier.com/content/article/PII:S0924857903000384?httpAccept=text/plain

1 reference

10.1016/S0924-8579(03)00038-4

https://api.crossref.org/works/10.1016/S0924-8579(03)00038-4

29 December 2023

International Journal of Antimicrobial Agents

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

425-433

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900038-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900038-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900038-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900038-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900038-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900038-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Differences between the activity of penicillin, amoxycillin, and co-amoxyclav against 5,252 Streptococcus pneumoniae isolates tested in the Alexander Project 1992-1996

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900038-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900038-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative In vitro surveillance study of gemifloxacin activities against 2,632 recent Streptococcus pneumoniae isolates from across Europe, North America, and South America. The Gemifloxacin Surveillance Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2803%2900038-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0924-8579(03)00038-4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44426764&oldid=2040089039"